Surgery for lone atrial fibrillation: Present state-of-the-art

Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery

Volumn 4, Issue 5, 2009, Pages 248-255

  Shen, Jeanne ^a   Bailey, Marci ^a   Damiano, Ralph J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ablation; Atrial fibrillation; Cox maze procedure.

Indexed keywords

ANTIARRHYTHMIC AGENT;

CATHETER ABLATION; CLINICAL EFFECTIVENESS; COX MAZE III PROCEDURE; DIAGNOSTIC ACCURACY; ELECTROSURGERY; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PULMONARY VEIN; REVIEW; SURGICAL TECHNIQUE; UNSPECIFIED SIDE EFFECT;

EID: 70349854831     PISSN: 15569845     EISSN: 15590879     Source Type: Journal    
DOI: 10.1097/IMI.0b013e3181bb370f     Document Type: Review

References (83)

1. Fuster V, Rydén LE, Cannom DS, et al. ACCÅHA SC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol. 2006;48:e149-e246. (Pubitemid 44175744)
2. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370-2375.
3. Damiano RJ Jr, Bailey M. The Cox-maze IV procedure for lone atrial fibrillation. MMCTS. 2007. Doi:10.1510/mmcts. 2007.002758.
4. Wolf PA, Abbott RD, Kannl WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983-988.
5. Benjamin EJ, Wolf PA, D'Agostino RB, et al. Impact of atrial fibril-lation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946-952.
6. Golzari H, Cebul RD, Bahler RC. Atrial fibrillation: restoration and maintenance of sinus rhythm and indications for anticoagulation therapy. Ann Intern Med. 1996;125:311-323.
7. Fang MC, Stafford RS, Ruskin JN, et al. National trends in antiarrhyth-mic and antithrombotic medication use in atrial fibrillation. Arch Intern Med. 2004;164:55-60.
8. Wijffels MC, Crijns HJ. Recent advances in drug therapy for atrial fibrillation. J Cardiovasc Electrophysiol. 2003;14(9 Suppl):S40-S47.
9. Miller MR, McNamara RL, Segal JB, et al. Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trial. J Fam Pract. 2000;49:1033-1046.
10. Boriani G, Diemberger I, Biffi M, et al. Pharmacological cardioversion of atrial fibrillation: Current management and treatment options. Drugs. 2004;64:2741-2762.
11. Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825-1833.
12. Corley SD, Epstein AE, DiMarco JP, et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study. Circulation. 2004;109:1509-1513.
13. Calkins H, Brugada J, Packer DL, et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrilla-tion: recommendations for personnel, policy, procedures and follow-up. Heart Rhythm. 2007;4:816-861.
14. Cox JL, Schuessler RB, D'Agostino HJ Jr, et al. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg. 1991;101:569-583.
15. Cox JL. The surgical treatment of atrial fibrillation. IV. Surgical technique. J Thorac Cardiovasc Surg. 1991;101:584-592.
16. Cox JL, Canavan TE, Schuessler RB, et al. The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the elcctrophysiologic basis of atrial flutter and atrial fibrillation. J Thorac Cardiovasc Surg. 1991;101:406-426.
17. Cox JL, Ad N, Palazzo T. Impact of the Maze procedure on the stroke rate in patients with atrial fibrillation. J Thorac Cardiovasc Surg. 1999;118:833-840.
18. Prasad SM, Maniar HS, Camillo CJ, et al. The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures. J Thorac Cardiovasc Surg. 2003;126: 1822-1827.
19. Damiano RJ Jr, Voeller RK. Biatrial lesion sets. J lnterv Card Elec-trophysiol. 2007;20:95-99.
20. McCarthy PM, Gillinov AM, Castle L, et al. The Cox-maze procedure: the Cleveland Clinic Experience. Semin Thorac Cardiovasc Surg. 2000;12:25-29.
21. Schaff HV, Dearani JA, Daly RC, et al. Cox-maze procedure for atrial fibrillation: Mayo Clinic Experience. Semin Thorac Cardiovasc Surg. 2000;12:30-37.
22. Arcidi JM Jr, Doty DB, Millar RC. The maze procedure: the LDS hospital experience. Semin Thorac Cardiovasc Surg. 2000;12:38-43.
23. Ballaux PKEW, Geuzebroek GSC, van Hemel NM, et al. Freedom from atrial arrhythmias after classic maze III surgery: a 10-year experience. J Thorac Cardiovasc Surg. 2006;132:1433-1440.
24. Jessurun ER, van Hemel NM, Defauw JAMT, et al. Results of maze surgery for lone paroxysmal atrial fibrillation. Circulation. 2000;101: 1559-1567.
25. Lönnerholm S, Blomström P, Nilsson L, et al. Effects of the maze operation on health-related quality of life in patients with atrial fibril-lation. Circulation. 2000;101:2607-2611.
26. Khargi K, Hutten BA, Lemke B, et al. Surgical treatment of atrial fibrillation: a systematic review. Eur J Cardio-thorac Surg. 2005;27: 258-265.
27. Damiano RJ Jr. Alternative energy sources for atrial ablation: judging the new technology. Ann Thorac Surg. 2003;75:329-330.
28. Melby SJ, Lee AM, Damiano RJ Jr. Advances in surgical ablation devices for atrial fibrillation. In: Naccarelli GV, Rosen MR, Estes NAM III, et al, eds. New Arrhythmia Technologies. Malden, MA: Blackwell Publishing; 2005;233-241.
29. Ad N, Cox JL. The maze procedure for the treatment of atrial fibril-lation: a minimally invasive approach. J Card Surg. 2004;19:196-200.
30. Damiano RJ Jr, Schuessler RB, Voeller RK. Surgical treatment of atrial fibrillation: a look into the future. Semin Thorac Cardiovasc Surg. 2007;9:39-45.
31. Melby SJ, Zierer A, Kaiser SP, et al. Epicardial microwave ablation on the beating heart for atrial fibrillation: the dependency of lesion depth on cardiac output. J Thorac Cardiovasc Surg. 2006;132:355-360.
32. Williams MR, Kourpanidis S, Casher J, et al. Epicardial atrial ablation with high intensity focused ultrasound on the beating heart. Circulation. 2001;104:II- 409.
33. Billard BE, Hynynen K, Roemer RB. Effects of physical parameters on high temperature ultrasound hyperthermia. Ultrasound Med Biol. 1990; 16:409-420.
34. Okumura Y, Kolasa MW, Johnson SB, et al. Mechanism of tissue heating during high intensity focused ultrasound pulmonary vein isolation: implications for atrial fibrillation ablation efficacy and phrenic nerve protection. J Cardiovasc Electrophysiol. 2008;19:945-951.
35. Gaynor SL, Ishii Y, Diodato MD, et al. Successful performance of the Cox-maze procedure on the beating heart using bipolar radiofrequency ablation: a feasibility study in animals. Ann Thorac Surg. 2004;78: 1671-1677.
36. Melby SJ, Gaynor SL, Lubahn JG, et al. Efficacy and safety of right and left atrial ablations on the beating heart with irrigated bipolar radiofrequency energy: a long-term animal study. J Thorac Cardiovasc Surg. 2006;132:853-860.
37. Hamner CE, Lutterman A, Potter DD, et al. Irrigated bipolar radiofre-quency ablation with transmurality feedback for the surgical Cox-maze procedure. Heart Surg Forum. 2003;6:418-423.
38. Damiano RJ Jr, Gaynor S. Atrial fibrillation ablation during mitral valve surgery using the Atricure device. Op Tech Thorac Cardiovasc Surg. 2004;9:24-33.
39. Lall SC, Melby SJ, Voeller RK, et al. The effect of ablation technology on surgical outcomes after the Cox-maze procedure: a propensity analysis. J Thorac Cardiovasc Surg. 2007;133:389-396.
40. Schmitt C, Ndrepepa G, Weber S, et al. Biatrial multisite mapping of atrial premature complexes triggering onset of atrial fibrillation. Am J Cardiol. 2002;89:1381-1387.
41. Chen SA, Hsieh MH, Tai CT, et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiolog-ical characteristics, pharmacological responses, and effects of radiofre-quency ablation. Circulation. 1999;100:1879-1886.
42. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659-666.
43. Nitta T, Ishii Y, Miyagi Y, et al. Concurrent multiple left atrial focal activations with fibrillatory conduction and right atrial focal or reentrant activation as the mechanism in atrial fibrillation. J Thorac Car-diovasc Surg. 2004;127:770-778.
44. Wolf RK, Schneeberger EW, Osterday R, et al. Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation. J Thorac Cardiovasc Surg. 2005;130:797-802.
45. Edgerton JR, Edgerton ZJ, Weaver T, et al. Minimally invasive pulmonary vein isolation and partial autonomic denervation for surgical treatment of atrial fibrillation. Ann Thorac Surg. 2008;86:35-39.
46. McClelland JH, Duke D, Reddy R. Preliminary results of limited thoracotomy: new approach to treat atrial fibrillation. J Cardiovas Electrophysiol. 2007;18:1289-1295.
47. Wudel JH, Chaudhuri P, Hiller JJ. Video-assisted epicardial ablation and left atrial appendage exclusion for atrial fibrillation: extended follow-up. Ann Thorac Surg. 2008;85:34-38.
48. Yilmaz A, Van Putte BP, Van Boven WJ. Completely thoracoscopic bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation. J Thorac Cardiovasc Surg. 2008;136:521-522.
49. Edgerton JR, Jackman WM, Mack M. Minimally invasive pulmonary vein isolation and partial autonomic denervation for surgical treatment of atrial fibrillation. J Interv Card Electrophysiol. 2007;20:89-93.
50. Sirak J, Jones D, Sun B, et al. Toward a definitive, totally thoracoscopic procedure for atrial fibrillation. Ann Thoracic Surgery. 2008;86:1960-1964.
51. Scherlag BJ, Nakagawa H, Jackman WM, et al. Electrical stimulation to identify neural elements on the heart: their role in atrial fibrillation. J Interv Card Electrophysiol. 2005;13:37-42.
52. Po SS, Scherlag BJ, Yamanashi WS, et al. Experimental model for paroxysmal atrial fibrillation arising at the pulmonary vein-atrial junction. Heart Rhythm. 2006;3:201-208.
53. Scheinman MM, Keung E. The year in clinical cardiac electrophysi-ology. J Am Coll Cardiol. 2007;49:2061-2069.
54. Platt M, Mandapati R, Scherlag BJ, et al. Limiting the number and extent of radiofrequency application to terminate atrial fibrillation and subsequently prevent its inducibility. Heart Rhythm. 2004;1:S11.
55. Mounsey JP. Recovery from vagal denervation and atrial fibrillation inducibility: effects are complex and not always predictable. Heart Rhythm. 2006;3:709-710.
56. Oh S, Zhang Y, Bibevski S, et al. Vagal denervation and atrial fibrillation inducibility: epicardial fat pad ablation does not have long-term effect. Heart Rhythm. 2006;3:701-708.
57. Sakamoto S, Schuessler RB, Lee A, et al. Focal ablation of epicardial ganglionated plexus: electrophysiological modification and regeneration of vagal tone in canine atria. Innov Technol Tech Cardiothorac Vasc Surg. 2008;3:67.
58. Katritsis D, Giazitzoglou E, Sougiannis D, et al. Anatomic approach for ganglionic plexi ablation in patients with paroxysmal atrial fibrillation. Am J Cardiol. 2008;102:330-334.
59. Schuessler RB, Kay MW, Melby SJ, et al. Spatial and temporal stability of the dominant frequency of activation in human atrial fibrillation. J Electrocardiol. 2006;39(suppl 4):S7-S12.
60. Berenfeld O, Mandapati R, Dixit S, et al. Spatially distributed dominant excitation frequencies reveal hidden organization in atrial fibrillation in the Langendorff-perfused sheep heart. J Cardiovasc Electrophysiol. 2000;11:869-879.
61. Sahadevan J, Ryu K, Peltz L, et al. Epicardial mapping of chronic atrial fibrillation in patients: preliminary observations. Circulation. 2004; 110:3293-3299.
62. Nattel S, Shiroshita-Takeshita A, Brundel BJ, et al. Mechanisms of atrial fibrillation: lessons from animal models. Prog Cardiovasc Dis. 2005;48:9-28. (Pubitemid 41368555)
63. Intini A, Goldstein RN, Jia P, et al. Electrocardiographic imaging (ECGI), a novel diagnostic modality used for mapping of focal left ventricular tachycardia in a young athlete. Heart Rhythm. 2005;2: 1250-1252.
64. Ghanem RN, Jia P, Ramanathan C, et al. Noninvasive electrocardiographic imaging (ECGI): comparison to intraoperative mapping in patients. Heart Rhythm. 2005;2:339-354.
65. Ramanathan C, Ghanem RN, Jia P, et al. Noninvasive electrocardiographic imaging for cardiac electrophysiology and arrhythmia. Nat Med. 2004;10:422-428.
66. Schuessler RB, Damiano RJ Jr. Patient-specific surgical strategy for atrial fibrillation: promises and challenge. Heart Rhythm. 2007;4:1222-1224.
67. Byrd GD, Prasad SM, Ripplinger CM, et al. Importance of geometry and refractory period in sustaining atrial fibrillation: testing the critical mass hypothesis. Circulation. 2005;112:I7-I13.
68. Kim KB, Rodefeld MD, Schuessler RB, et al. Relationship between local atrial fibrillation interval and refractory period in the isolated canine atrium. Circulation. 1996;94:2961-2967.
69. Barnette AR, Bayly PV, Zhang S, et al. Estimation of 3-D conduction velocity vector fields from cardiac mapping data. IEEE Trans Biomed Eng. 2000;47:1027-1035.
70. Gillinov AM, Sirak J, Blackstone EH, et al. The Cox maze procedure in mitral valve disease: predictors of recurrent atrial fibrillation. J Tho-rac Cardiovasc Surg. 2005;130:1653-1660.
71. Kosakai Y. Treatment of atrial fibrillation using the Maze procedure: the Japanese experience. Semin Thorac Cardiovasc Surg. 2000;12:44-52.
72. Feinberg MS, Waggoner AD, Kater KM, et al. Restoration of atrial function after the maze procedure for patients with atrial fibrillation. Assessment by doppler echocardiography. Circulation. 1994;90(5 Pt 2):II285-II292.
73. Itoh T, Okamoto H, Nimi T, et al. Left atrial function after Cox's maze operation concomitant with mitral valve operation. Ann Thorac Surg. 1995;60:354-359.
74. Albirini A, Scalia GM, Murray RD, et al. Left and right atrial transport function after the maze procedure for atrial fibrillation: an echocardio-graphic doppler follow-up study. J Am Soc Echocardiogr. 1997;10: 937-945.
75. Lee JW, Choo SJ, Kim KI, et al. Atrial fibrillation surgery simplified with cryoablation to improve left atrial function. Ann Thorac Surg. 2001;72:1479-1483.
76. Jessurun ER, van Hemel NM, Kelder JC, et al. The effect of maze operations on atrial volume. Ann Thorac Surg. 2003;75:51-56.
77. Muraki S, Tsukamoto M, Kobayashi T, et al. Preserved atrial response to dobutamine stress after the modified maze procedure for chronic atrial fibrillation: echocardiographic assessment of atrial function. J Card Surg. 2002;17:148-154.
78. Lönnerholm S, Blomström P, Nilsson L, et al. Atrial size and transport function after the Maze III procedure for paroxysmal atrial fibrillation. Ann Thorac Surg. 2002;73:107-111.
79. Kim YJ, Sohn DW, Park DG, et al. Restoration of atrial mechanical function after maze operations in patients with structural heart disease. Am Heart J. 1998;136:1070-1074.
80. Cox JL. Atrial transport function after the maze procedure for atrial fibrillation: a 10-year clinical experience. Am Heart J. 1998;136:934-936.
81. Yashima N, Nasu M, Kawazoe K, et al. Serial evaluation of atrial function by Doppler echocardiography after the maze procedure for chronic atrial fibrillation. Eur Heart J. 1997;18:496-502.
82. Darpo B, Ryden L. Restoration of atrial function after the maze procedure. Eur Heart J. 1997;18:360-361.
83. Voeller RK, Zierer A, Lall SC, et al. The effects of the Cox maze procedure on atrial function. J Thorac Cardiovasc Surg. 2008;136: 1257-1264, 1264.e1-3